Semaglutide GLP-1 receptor agonist Treatment of type 2 diabetes

Chudleigh, R; Bain, SC

Bain, SC (reprint author), Swansea Univ, Sketty Lane, Swansea SA2 8PP, W Glam, Wales.

DRUGS OF THE FUTURE, 2017; 42 (8): 479

Abstract

Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue in development for the treatment of type 2 diabetes (T2D). It has 94% homology to native GLP......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索